{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:18Z","timestamp":1787729478909,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.trsl.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:36:13Z","timestamp":1395534973000},"page":"139-148","source":"Crossref","is-referenced-by-count":64,"title":["Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response"],"prefix":"10.1016","volume":"164","author":[{"given":"Dominic W.","family":"Pelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Ringler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline D.","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kampfschulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Donald J.","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna S.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2014.03.005_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/1097-0142(196902)23:2<371::AID-CNCR2820230213>3.0.CO;2-2","article-title":"Aneurysmal bone cyst: pathology, clinical course and radiologic appearances","volume":"23","author":"Dabska","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2014.03.005_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5435\/JAAOS-20-04-233","article-title":"Aneurysmal bone cyst","volume":"20","author":"Rapp","year":"2012","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.trsl.2014.03.005_bib3","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1200\/JCO.2005.15.255","article-title":"Aneurysmal bone cyst: a review of 150 patients","volume":"23","author":"Mankin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.bpo.0000158002.30800.8f","article-title":"Aneurysmal bone cysts of the pelvis in children: a multicenter study and literature review","volume":"25","author":"Cottalorda","year":"2005","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.trsl.2014.03.005_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00003086-199906000-00023","article-title":"Aneurysmal bone cyst: a population based epidemiologic study and literature review","volume":"363","author":"Leithner","year":"1999","journal-title":"Clin Orthop Rel Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<265::AID-GCC12>3.0.CO;2-#","article-title":"Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts","volume":"26","author":"Panoutsakopoulos","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.trsl.2014.03.005_bib7","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)63432-3","article-title":"USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts","volume":"165","author":"Oliveira","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2014.03.005_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ocl.2008.09.009","article-title":"Management of benign tumors of the mobile spine","volume":"40","author":"Gasbarrini","year":"2009","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/j.trsl.2014.03.005_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1227\/NEU.0b013e31822b8107","article-title":"Primary vertebral tumors: a review of epidemiologic, histological, and imaging findings, part I: benign tumors","volume":"69","author":"Ropper","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.trsl.2014.03.005_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.5435\/JAAOS-20-11-715","article-title":"Benign tumors of the spine","volume":"20","author":"Thakur","year":"2012","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.trsl.2014.03.005_bib11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2106\/00004623-200111000-00009","article-title":"Treatment of aneurysmal bone cysts of the pelvis and sacrum","volume":"83A","author":"Papagelopoulos","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.trsl.2014.03.005_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00586-012-2510-x","article-title":"Aneurysmal bone cysts of the spine","volume":"22","author":"Zileli","year":"2013","journal-title":"Eur Spine J"},{"key":"10.1016\/j.trsl.2014.03.005_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00007632-199803010-00018","article-title":"Aneurysmal bone cyst of the spine: management and outcome","volume":"23","author":"Papagelopoulos","year":"1998","journal-title":"Spine"},{"key":"10.1016\/j.trsl.2014.03.005_bib14","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.3928\/01477447-20120525-43","article-title":"Successful treatment of aggressive aneurysmal bone cyst of the pelvis with serial embolization","volume":"35","author":"Rossi","year":"2012","journal-title":"Orthopedics"},{"key":"10.1016\/j.trsl.2014.03.005_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2014.03.005_bib16","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2014.03.005_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2014.03.005_bib18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2014.03.005_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2141.2004.05024.x","article-title":"Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen","volume":"126","author":"Bord","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2014.03.005_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","article-title":"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation","volume":"156","author":"Huang","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2014.03.005_bib21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","article-title":"Expression of osteoclast differentiation signals by stromal elements of giant cell tumors","volume":"15","author":"Atkins","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","article-title":"RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone","volume":"117","author":"Roux","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.trsl.2014.03.005_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2014.03.005_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00003086-198603000-00007","article-title":"Characterization of cells from human giant cell tumors of bone","volume":"204","author":"Goldring","year":"1986","journal-title":"Clin Orthop Rel Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.trsl.2014.03.005_bib26","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PAT.0b013e3283463536","article-title":"RANK signalling in bone lesions with osteoclast-like giant cells","volume":"43","author":"Won","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.trsl.2014.03.005_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/CCO.0b013e328354c129","article-title":"RANKL, denosumab, and giant cell tumor of bone","volume":"24","author":"Thomas","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib32","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1056\/NEJMc060819","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"Rifkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2014.03.005_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2014.03.005_bib34","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.juro.2009.08.048","article-title":"Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer","volume":"182","author":"Smith","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.trsl.2014.03.005_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2012.06674.x","article-title":"The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction","volume":"1263","author":"Goessl","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trsl.2014.03.005_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2012.02.002","article-title":"Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data","volume":"34","author":"Dempster","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.trsl.2014.03.005_bib37","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates","volume":"27","author":"Fizazi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib38","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib40","first-page":"331","article-title":"Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients","volume":"7","author":"Yee","year":"2012","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.trsl.2014.03.005_bib41","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trsl.2014.03.005_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lab.2004.06.005","article-title":"Gene expression in giant-cell tumors","volume":"144","author":"Skubitz","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2014.03.005_bib43","series-title":"WHO classification of tumours of soft tissue and bone","author":"Fletcher","year":"2013"},{"key":"10.1016\/j.trsl.2014.03.005_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1034\/j.1600-0714.2003.00126.x","article-title":"Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts","volume":"32","author":"Liu","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.trsl.2014.03.005_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/labinvest.2012.5","article-title":"CD14\u2013 mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst","volume":"92","author":"Taylor","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2014.03.005_bib46","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/dvdy.21719","article-title":"Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance","volume":"237","author":"Peacock","year":"2008","journal-title":"Dev Dyn"},{"key":"10.1016\/j.trsl.2014.03.005_bib47","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/0008-5472.CAN-03-2827","article-title":"USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst","volume":"64","author":"Oliveira","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s11547-011-0670-0","article-title":"Selective arterial embolisation for bone tumours: experience of 454 cases","volume":"116","author":"Rossi","year":"2011","journal-title":"Radiol Med"},{"key":"10.1016\/j.trsl.2014.03.005_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3171\/PED.2008.2.11.365","article-title":"Percutaneous intralesional injection of calcitonin and methylprednisolone for treatment of an aneurysmal bone cyst at C-2","volume":"2","author":"Ohashi","year":"2008","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.trsl.2014.03.005_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/BPB.0b013e32832f724c","article-title":"Long-term follow-up of Ethibloc injection in aneurysmal bone cysts","volume":"18","author":"George","year":"2009","journal-title":"J Pediatr Orthop B"},{"key":"10.1016\/j.trsl.2014.03.005_bib51","first-page":"1883","article-title":"Fatal Ethibloc embolization of vertebrobasilar system following percutaneous injection into aneurysmal bone cyst of the second cervical vertebra","volume":"26","author":"Turowski","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.trsl.2014.03.005_bib52","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(00)01462-0","article-title":"Megavoltage radiotherapy for aneurysmal bone cysts","volume":"49","author":"Feigenberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.trsl.2014.03.005_bib53","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1750-1172-7-S1-S3","article-title":"Pathophysiology and medical treatment of pain in fibrous dysplasia of bone","volume":"7","author":"Chapurlat","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2014.03.005_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11999-009-0914-7","article-title":"Argon beam coagulation as adjuvant treatment after curettage of aneurysmal bone cysts: a preliminary study","volume":"468","author":"Cummings","year":"2010","journal-title":"Clin Orthop Rel Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib55","first-page":"157","article-title":"The treatment of aneurysmal bone cyst","volume":"311","author":"Marcove","year":"1995","journal-title":"Clin Orthop Rel Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib56","first-page":"74","article-title":"Aneurysmal bone cysts of the sacrum: a report of ten cases and review of the literature","volume":"29","author":"Brastianos","year":"2009","journal-title":"Iowa Orthop J"},{"key":"10.1016\/j.trsl.2014.03.005_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00402-006-0223-5","article-title":"Modern concepts of primary aneurysmal bone cyst","volume":"127","author":"Cottalorda","year":"2007","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.trsl.2014.03.005_bib58","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00256-011-1202-7","article-title":"Advance in the treatment of aneurysmal bone cyst of the sacrum","volume":"40","author":"Donati","year":"2011","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.trsl.2014.03.005_bib59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70170-4","article-title":"Safety of denosumab in giant-cell tumour of bone","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2014.03.005_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X11424220","article-title":"A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis","volume":"3","author":"Miller","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.trsl.2014.03.005_bib61","first-page":"42","article-title":"Denosumab for the treatment of osteoporosis: a systematic literature review","volume":"9","author":"Silva-Fernandez","year":"2013","journal-title":"Rheumatol Clin"},{"key":"10.1016\/j.trsl.2014.03.005_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.trsl.2014.03.005_bib63","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2014.03.005_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1148\/rg.331125089","article-title":"Giant cell tumor of bone: review, mimics, and new developments in treatment","volume":"33","author":"Chakarun","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.trsl.2014.03.005_bib65","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00586-013-2715-7","article-title":"Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts","volume":"22","author":"Lange","year":"2013","journal-title":"Eur Spine J"},{"key":"10.1016\/j.trsl.2014.03.005_bib66","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.trsl.2014.03.005_bib67","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2014.03.005_bib68","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/1097-0142(197712)40:6<2967::AID-CNCR2820400632>3.0.CO;2-I","article-title":"Ultrastructure of aneurysmal bone cyst","volume":"40","author":"Steiner","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2014.03.005_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00429610","article-title":"Aneurysmal bone cyst: a study of ultrastructure and malignant transformation","volume":"395","author":"Aho","year":"1982","journal-title":"Virchow Arch A Pathol Anat Histol"},{"key":"10.1016\/j.trsl.2014.03.005_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0046-8177(86)80153-8","article-title":"Immunocytochemical markers (endothelial and histiocytic) and ultrastructure of primary aneurysmal bone cysts","volume":"17","author":"Alles","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.trsl.2014.03.005_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/ecp.12.35","article-title":"Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors","volume":"5","author":"Lipton","year":"2012","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.trsl.2014.03.005_bib72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.juro.2009.04.023","article-title":"Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial","volume":"182","author":"Fizazi","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.trsl.2014.03.005_bib73","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524414000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524414000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:42:48Z","timestamp":1648672968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524414000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1931524414000899"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2014.03.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}